LOS ANGELES, Jan. 25, 2018 /PRNewswire/ — Stellar Biotechnologies, Inc. (Nasdaq: SBOT), a leading manufacturer of a key protein utilized in multiple immunotherapy development pipelines targeting Alzheimer’s, diabetes, lupus and cancers, among other diseases, today announced the…